Your browser doesn't support javascript.
loading
Bispecific CD3-HAC carried by E1A-engineered mesenchymal stromal cells against metastatic breast cancer by blocking PD-L1 and activating T cells.
Yang, Yuanyuan; Zhang, Xiaolong; Lin, Fangzhen; Xiong, Mengshang; Fan, Dongmei; Yuan, Xiangfei; Lu, Yang; Song, Yuewen; Zhang, Yizi; Hao, Mu; Ye, Zhou; Zhang, Yanjun; Wang, Jianxiang; Xiong, Dongsheng.
Afiliación
  • Yang Y; State Key Laboratory of Experimental HematologyInstitute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, 300020, People's Republic of China.
  • Zhang X; Department of Pharmacy, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, People's Republic of China.
  • Lin F; State Key Laboratory of Experimental HematologyInstitute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, 300020, People's Republic of China.
  • Xiong M; State Key Laboratory of Experimental HematologyInstitute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, 300020, People's Republic of China.
  • Fan D; State Key Laboratory of Experimental HematologyInstitute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, 300020, People's Republic of China.
  • Yuan X; Tianjin Institute of Integrative Medicine for Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin, 300100, People's Republic of China.
  • Lu Y; State Key Laboratory of Experimental HematologyInstitute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, 300020, People's Republic of China.
  • Song Y; State Key Laboratory of Experimental HematologyInstitute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, 300020, People's Republic of China.
  • Zhang Y; Central Hospital of Karamay, Karamay, Xinjiang, 834000, People's Republic of China.
  • Hao M; State Key Laboratory of Experimental HematologyInstitute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, 300020, People's Republic of China.
  • Ye Z; Central Hospital of Karamay, Karamay, Xinjiang, 834000, People's Republic of China. yezhou126@126.com.
  • Zhang Y; State Key Laboratory of Experimental HematologyInstitute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, 300020, People's Republic of China. junjunfriend@126.com.
  • Wang J; State Key Laboratory of Experimental HematologyInstitute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, 300020, People's Republic of China. wangjx@ihcams.ac.cn.
  • Xiong D; State Key Laboratory of Experimental HematologyInstitute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, 300020, People's Republic of China. dsxiong@ihcams.ac.cn.
J Hematol Oncol ; 12(1): 46, 2019 04 25.
Article en En | MEDLINE | ID: mdl-31023384
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Linfocitos T / Complejo CD3 / Células Madre Mesenquimatosas / Antígeno B7-H1 Límite: Animals / Female / Humans Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Linfocitos T / Complejo CD3 / Células Madre Mesenquimatosas / Antígeno B7-H1 Límite: Animals / Female / Humans Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido